GeneDx Holdings Corp - Ordinary Shares - Class A
WGS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.06B
Close$
$-140.29
302.3% downside
Current Fair Value
302.3% downsideOvervalued by 302.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.06 Billion |
|---|---|
| Enterprise Value | $2.17 Billion |
| Earnings per Share | $-0.73 |
| Beta | 1.97 |
| Outstanding Shares | 29,710,139 |
Return
| Return on Equity | -43.55% |
|---|---|
| Return on Assets | -22.09% |
| Return on Invested Capital | -16.55% |
Valuation & Multiples
| P/E Ratio | -18.97 |
|---|---|
| PEG | 7.18 |
| Price to Sales | 4.62 |
| Price to Book Ratio | 8.67 |
| Enterprise Value to Revenue | 4.77 |
| Enterprise Value to EBIT | -32.17 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$122.93 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 35.41% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.09%▼ 103.16% |
|---|---|
| Total Invested | $109.38M▼ 94.98% |
| Investors Holding | 40▼ 200.00% |
About GeneDx Holdings Corp
3 employees
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and g...